Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | ALK |
Variant | D1091N |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | ALK D1091N lies within the cytoplasmic domain of the Alk protein (UniProt.org). D1091N results in increased ERK activation in the presence of agonist antibodies (PMID: 23104988), but does not transform cultured cells (PMID: 23104988), and therefore, its effect on Alk protein function is unknown. |
Associated Drug Resistance | |
Category Variants Paths |
ALK mutant ALK D1091N |
Transcript | NM_004304.5 |
gDNA | chr2:g.29223430C>T |
cDNA | c.3271G>A |
Protein | p.D1091N |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_004304 | chr2:g.29223430C>T | c.3271G>A | p.D1091N | RefSeq | GRCh38/hg38 |
NM_004304.4 | chr2:g.29223430C>T | c.3271G>A | p.D1091N | RefSeq | GRCh38/hg38 |
NM_004304.5 | chr2:g.29223430C>T | c.3271G>A | p.D1091N | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|